NEUROLOGIX
Neurologix, Inc., a development stage company, engages in the discovery and development of therapeutic treatments for disorders of the brain and central nervous system. The company's treatments are designed as alternatives to conventional surgical and pharmacological treatments. It primarily focuses on gene therapy for treating Parkinson's disease, a neurodegenerative disorder; and epilepsy, a group of diseases associated with recurrent seizures, which is caused by periodic episodes of repetitiv... e, abnormal electrochemical disturbance in the central nervous system, beginning in the brain. The company also focuses on the development of gene transfers for the treatment of neurodegenerative and metabolic disorders, including Huntington's disease, depression, and metabolic syndrome or genetically-based obesity. Neurologix, Inc. was founded in 1999 and is based in Fort Lee, New Jersey.
NEUROLOGIX
Industry:
Biotechnology Genetics Medical Therapeutics
Founded:
1999-01-01
Address:
Fort Lee, New Jersey, United States
Country:
United States
Website Url:
http://www.neurologix.net
Total Employee:
1+
Status:
Active
Contact:
(201)592-6451
Total Funding:
7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Neurofix
Neurofix mission is to discover and develop molecules for the treatment of pathologies of the central nervous system.
Current Employees Featured
Founder
Stock Details
Investors List
Palisade Capital Management
Palisade Capital Management investment in Venture Round - Neurologix
Corriente Advisors
Corriente Advisors investment in Venture Round - Neurologix
General Electric Pension Trust
General Electric Pension Trust investment in Venture Round - Neurologix
Official Site Inspections
http://www.neurologix.net
- Host name: 172.67.184.86
- IP address: 172.67.184.86
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Neurologix"
Neurologix - Org Chart, Teams, Culture & Jobs - The Org
View Neurologix's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Neurologix - Crunchbase Company Profile & Funding
Neurologix, Inc., a development stage company, engages in the discovery and development of therapeutic treatments for disorders of the brain and central …See details»
Neurologix, Inc. - Crunchbase Company Profile
Neurologix takes a holistic approach to wellness with a complete system of nutrient-based products (dietary supplements, nootropics, nutraceuticals), …See details»
Neurologix Company Profile 2024: Valuation, Funding …
Neurologix Inc is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of life-altering gene transfer …See details»
Neurologix Inc (NRGXQ) Profile - The Globe and Mail
See the company profile for Neurologix Inc (NRGXQ) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Leadership Team - Team at Neurologix - The Org
The current leadership team at Neurologix has a diverse range of experience in finance and engineering. The team includes individuals who have worked at companies such as Amazon …See details»
Neurologix - Overview, News & Similar companies | ZoomInfo.com
Neurologix, Inc. (OTCBB:NRGX) is a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of life-alter ing gene transfer therapies for …See details»
Neurologix, Inc. Receives FDA Clearance to Initiate Phase 2
Mar 27, 2008 · Neurologix, Inc. (NRGX.OB) is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of life-altering gene transfer therapies …See details»
Company Neurologix, Inc. - MarketScreener.com
Neurologix, Inc. engages in the research and development of gene transfer therapies for the treatment for brain disorders and central nervous system diseases. The company programs …See details»
Neurologix - Products, Competitors, Financials, Employees, …
Neurologix specializes in personalized nutrient-based products for enhancing physical and cognitive performance, operating within the health and wellness industry. Use the CB Insights …See details»
Neurologix, Inc. Licenses Exclusive Rights to Key Gene from Aegera ...
Sep 3, 2008 · Neurologix, Inc. (NRGX.OB) is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of life-altering gene transfer therapies for …See details»
Neurologix Announces Successful Phase 2 Trial of Gene Therapy …
Jun 22, 2010 · Neurologix's investigational AAV (adeno-associated virus) vector gene therapy, NLX-P101, is a novel, non-dopaminergic approach that uses an inhibitory gene (glutamic acid …See details»
New Details Presented at the World Parkinson Congress on …
Oct 1, 2010 · Neurologix's investigational AAV (adeno-associated virus) vector gene therapy, NLX-P101, is a novel, non-dopaminergic approach that uses an inhibitory gene (glutamic acid …See details»
NeuroLogix
NeuroLogix specializes in mobile data collection and cloud-based visualization of neurologic performance. This allows for seamless sharing of information to all HCPs, greater continuity of …See details»
Neurologix presents 1-year data from phase 2 | EurekAlert!
May 26, 2011 · Neurologix, Inc. (OTCBB:NRGX) is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of life-altering gene transfer …See details»
Neurologix Completes All Surgical Procedures in Its Clinical Trial …
Dec 11, 2009 · Neurologix, Inc. (NRGX.OB) is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of life-altering gene transfer therapies …See details»
Neurologix Developmental Clinic – Neurologix Developmental Clinic
Simply email us on [email protected] or call us on (08) 6146 3170 to book an appointment. Do I require a referral? Complex Neurodevelopmental Assessments: We prefer …See details»
Neurologix announces positive results of gene | EurekAlert!
FORT LEE, N.J., Sept. 26, 2005 -- Neurologix, Inc. (OTCBB:NRGX) today announced positive interim results of its landmark gene therapy clinical trial for patients with Parkinson's disease.See details»
Home - NuraLogix
Aug 11, 2023 · Consult with a health care professional or emergency services if you believe you may have a medical issue. Using a conventional video camera, our cloud-based Affective AI …See details»
Neuralogix
We specialize in EEG solutions utilizing state-of-the-art equipment specifically for physician practices and hospital facilities while also providing patients the comfort of in-home ambulatory …See details»